01/14/2020
In this podcast, Laszlo L. Mechtler, MD, from the Dent Neurologic Institute, discusses the role of neuroimaging in diagnosing headache disorders, which patient populations are indicated for neuroimaging, and some of the common questions he receives about neuroimaging for headache disorders.
Additional Resources:
- IHS Classification ICHD-3. International Headache Society. Updated: 2019. https://ichd-3.org/1-migraine. Accessed August 9, 2019.
- Imaging: do i need an imaging study for my headache? American Academy of Neurology and American Headache Society. Updated: 2014. https://www.aan.com/siteassets/home-page/policy-and-guidelines/quality/quality-improvement/patient-handouts/14headacheimagingsdmtool_pg.pdf. Accessed August 9, 2019.
- Silberstein S. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6). https://doi.org/10.1212/WNL.55.6.754.
- American College of Radiology. Don’t do imaging for uncomplicated headache. Choosing Wisely. Published: April 4, 2012. Updated: June 29, 2017. https://www.choosingwisely.org/clinician-lists/american-college-radiology-imaging-for-uncomplicated-headache. Accessed August 9, 2019.
Laszlo L. Mechtler, MD, is the medical director and director of the Headache/Neuro-Oncology Center at Dent Neurologic Institute and chief of Neuro-Oncology at Roswell Park Cancer Institute in Amherst, New York. He is also the Immediate Past President of the American Society of Neuroimaging (ASN) and current chair of the AAN Neuroimaging Section.